Market Research Logo

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Surgery, and aGVHD), Cell Source (Adipose tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs) - Global Forecasts to 2021

The global stem cell therapy market is estimated to grow at a CAGR of 11.0% during 2016 to 2021 to reach USD 145.8 million by 2021. Growth in the global stem cell therapy market is driven by factors such as the growing awareness of the therapeutic potency of stem cells in effective disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for development of stem cell therapies, identification of new stem cell lines, and developments in infrastructure related to stem cell banking and processing. In addition, countries such as Japan, South Korea, and China are offering new growth opportunities for players operating in this market. The North American region is expected to command the largest share in the stem cell therapy market in 2016.

Based on the type of therapy, the allogeneic stem cell therapy segment is estimated to command the larger share of the global stem cell therapy market in 2016. This growth can be attributed to the growing availability of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easier production scale-up due to easy availability of sources of stem cells, and growing number of clinical trials of allogeneic stem cell therapies as compared to autologous stem cell therapies.

The stem cell therapy market is niche industry with a growing number of global and local companies involved in the development and commercialization of stem cell therapy products. Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), and Pharmicell Co., Ltd. (South Korea) were the leading players in the global stem cell therapy market in 2015. New product launches and approvals; expansions; and partnerships and agreements are the major strategies adopted by most of the market players to achieve growth in the stem cell therapy market during 2013–2016.

Research Coverage
This report studies stem cell therapy market based on type of therapy (allogeneic and autologous). These stem cell therapies are used for the treatment of various diseases (including musculoskeletal disorders, wound healing, CVDs, and GI diseases, among others). The report also studies, the factors (such as drivers, restraints, opportunities, and challenges) which affect the market growth in a positive and negative manner. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report forecasts the revenue of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The stem cell therapy market report strategically profiles the key players who are involved in the manufacturing and commercialization of stem cell therapy products and comprehensively analyze their market ranking and core competencies. The report tracks and analyzes competitive developments such as new product launches and enhancements; expansions; and partnerships and agreements in the stem cell therapy market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis—market share analysis of the top players and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the stem cell therapy market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on products offered by the top 10 players in the stem cell therapy market. The report analyzes the stem cell therapy market by type, therapeutic application, cell source, and region

Product Development/Innovation: Detailed insights on research and development activities, developmental product pipeline, and new product launches in the stem cell therapy market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various stem cell therapy products across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World)

Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the stem cell therapy market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • GEOGRAPHIC SCOPE
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • RESEARCH ASSUMPTIONS
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CONCLUSION
  • PREMIUM INSIGHTS
    • STEM CELL THERAPY MARKET OVERVIEW
    • REGIONAL ANALYSIS: STEM CELL THERAPY MARKET, BY TYPE, 2016 VS. 2021 (USD MILLION)
    • GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION, 2016-2021 (USD MILLION)
    • REGIONAL ANALYSIS: STEM CELL THERAPY MARKET, BY CELL SOURCE, 2016 VS. 2021 (USD MILLION)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • MARKET GROWTH DRIVERS
        • Table RECENTLY LAUNCHED CELL ANALYSIS PRODUCTS (2015-2017)
      • MARKET RESTRAINTS
      • MARKET GROWTH OPPORTUNITIES
      • MARKET CHALLENGES
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
        • Table NORTH AMERICA: REGULATORY LANDSCAPE FOR STEM CELL THERAPY (AS OF 2016)
      • EUROPE
        • Table EUROPE: REGULATORY LANDSCAPE FOR STEM CELL THERAPY (AS OF 2016)
      • ASIA-PACIFIC
        • Table ASIA-PACIFIC: REGULATORY LANDSCAPE FOR STEM CELL THERAPY (AS OF 2016)
      • REST OF THE WORLD
        • Table ROW: REGULATORY LANDSCAPE FOR STEM CELL THERAPY (AS OF 2016)
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • SUPPLY CHAIN ANALYSIS
      • KEY STAKEHOLDERS
      • KEY INFLUENCERS
    • PIPELINE ANALYSIS
      • PIPELINE ANALYSIS: BASED ON PHASE OF CLINICAL STUDY
      • PIPELINE ANALYSIS: BASED ON TYPE
      • PIPELINE ANALYSIS: BASED ON THE CELL LINE USED
  • GLOBAL STEM CELL THERAPY MARKET, BY TYPE
    • INTRODUCTION
      • Table GLOBAL STEM CELL THERAPY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
    • ALLOGENEIC STEM CELL THERAPY MARKET, BY APPLICATION
      • Table GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • MUSCULOSKELETAL DISORDERS
        • Table ALLOGENEIC STEM CELL THERAPY MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2014-2021 (USD MILLION)
      • WOUNDS AND INJURIES
        • Table ALLOGENEIC STEM CELL THERAPY MARKET SIZE FOR WOUNDS AND INJURIES, BY REGION, 2014-2021 (USD MILLION)
      • SURGERIES
        • Table ALLOGENEIC STEM CELL THERAPY MARKET SIZE FOR SURGERIES, BY REGION, 2014-2021 (USD MILLION)
      • ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD)
        • Table ALLOGENEIC STEM CELL THERAPY MARKET SIZE FOR ACUTE GRAFT-VERSUS-HOST DISEASE, BY REGION, 2014-2021 (USD MILLION)
      • OTHER APPLICATIONS
        • Table ALLOGENEIC STEM CELL THERAPY MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
    • AUTOLOGOUS STEM CELL THERAPY MARKET, BY APPLICATION
      • Table GLOBAL AUTOLOGOUS STEM CELL THERAPY MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
      • Table GLOBAL AUTOLOGOUS STEM CELL THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • WOUNDS AND INJURIES
        • Table AUTOLOGOUS STEM CELL THERAPY MARKET FOR WOUNDS AND INJURIES, BY REGION, 2014-2021 (USD MILLION)
      • CARDIOVASCULAR DISEASES
        • Table AUTOLOGOUS STEM CELL THERAPY MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY REGION, 2014-2021 (USD MILLION)
      • GASTROINTESTINAL DISEASES
        • Table AUTOLOGOUS STEM CELL THERAPY MARKET SIZE FOR GASTROINTESTINAL DISEASES, BY REGION, 2014-2021 (USD MILLION)
      • OTHER APPLICATIONS
        • Table AUTOLOGOUS STEM CELL THERAPY MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • GLOBAL STEM CELL THERAPY MARKET, BY THERAPEUTIC APPLICATION
    • INTRODUCTION
      • Table GLOBAL STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
    • MUSCULOSKELETAL DISORDERS
      • Table STEM CELL THERAPY MARKET SIZE FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2014-2021 (USD MILLION)
    • WOUNDS AND INJURIES
      • Table STEM CELL THERAPY MARKET SIZE FOR WOUNDS AND INJURIES, BY REGION, 2014-2021 (USD MILLION)
    • CARDIOVASCULAR DISEASES
      • Table STEM CELL THERAPY MARKET SIZE FOR CARDIOVASCULAR DISEASES, BY REGION, 2014-2021 (USD MILLION)
    • SURGERIES
      • Table STEM CELL THERAPY MARKET SIZE FOR SURGERIES, BY REGION, 2014-2021 (USD MILLION)
    • GASTROINTESTINAL DISEASES
      • Table STEM CELL THERAPY MARKET SIZE FOR GASTROINTESTINAL DISEASES, BY REGION, 2014-2021 (USD MILLION)
    • OTHER APPLICATIONS
      • Table STEM CELL THERAPY MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • GLOBAL STEM CELL THERAPY MARKET, BY CELL SOURCE
    • INTRODUCTION
      • Table GLOBAL STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2014-2021 (USD MILLION)
    • ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS
      • Table STEM CELL THERAPY MARKET SIZE FOR ADIPOSE TISSUE-DERIVED MSCS, BY REGION, 2014-2021 (USD MILLION)
    • BONE MARROW-DERIVED MESENCHYMAL STEM CELLS
      • Table STEM CELL THERAPY MARKET SIZE FOR BONE MARROW-DERIVED MSCS, BY REGION, 2014-2021 (USD MILLION)
    • CORD BLOOD/EMBRYONIC STEM CELLS
      • Table STEM CELL THERAPY MARKET SIZE FOR CORD BLOOD/EMBRYONIC STEM CELLS, BY REGION, 2014-2021 (USD MILLION)
    • OTHER CELL SOURCES
      • Table STEM CELL THERAPY MARKET SIZE FOR OTHER CELL SOURCES, BY REGION, 2014-2021 (USD MILLION)
  • STEM CELL THERAPY MARKET, BY REGION
    • INTRODUCTION
      • Table STEM CELL THERAPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: STEM CELL THERAPY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: STEM CELL THERAPY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
      • Table EUROPE: STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2014-2021 (USD MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: STEM CELL THERAPY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: STEM CELL THERAPY MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: STEM CELL THERAPY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
      • Table ROW: STEM CELL THERAPY MARKET SIZE, BY CELL SOURCE, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING
    • STRATEGIC BENCHMARKING
      • PRODUCT DEVELOPMENT AND COMMERCIALIZATION
    • COMPETITIVE SCENARIO
    • RECENT DEVELOPMENTS
      • PRODUCT LAUNCHES AND APPROVALS
        • Table TOP PRODUCTLAUNCHES AND APPROVALS (2013-2016)
      • EXPANSIONS
        • Table TOP EXPANSIONS (2013 - 2016)
      • AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
        • Table TOP AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS (2013-2016)
  • COMPANY PROFILES
    • INTRODUCTION
      • GEOGRAPHIC BENCHMARKING
    • OSIRIS THERAPEUTICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table OSIRIS THERAPEUTICS, INC.: STEM CELL THERAPY PRODUCTS OFFERED
        • Table OSIRIS THERAPEUTICS, INC.: STEM CELL THERAPY PRODUCT PIPELINE
      • KEY DEVELOPMENTS
      • MNM VIEW
    • MEDIPOST CO., LTD.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table MEDIPOST CO., LTD.: STEM CELL THERAPY PRODUCTS OFFERED
        • Table MEDIPOST CO., LTD.: STEM CELL THERAPY PRODUCT PIPELINE
      • KEY DEVELOPMENTS
      • MNM VIEW
    • ANTEROGEN CO., LTD.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table ANTEROGEN CO., LTD.: STEM CELL THERAPY PRODUCTS OFFERED
        • Table ANTEROGEN CO., LTD.: STEM CELL THERAPY PRODUCT PIPELINE
      • KEY DEVELOPMENTS
      • MNM VIEW
    • PHARMICELL CO., LTD.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table PHARMICELL CO., LTD.: STEM CELL THERAPY PRODUCTS OFFERED
        • Table PHARMICELL CO., LTD.: STEM CELL THERAPY PRODUCT PIPELINE
      • KEY DEVELOPMENTS
      • MNM VIEW
    • HOLOSTEM TERAPIE AVANZATE SRL
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table HOLOSTEM TERAPIE AVANZATE SRL: STEM CELL THERAPY PRODUCTS OFFERED
      • KEY DEVELOPMENTS
    • JCR PHARMACEUTICALS CO., LTD.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table JCR PHARMACEUTICALS CO., LTD.:STEM CELL THERAPY PRODUCTS OFFERED
      • KEY DEVELOPMENTS
    • NUVASIVE, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table NUVASIVE, INC.:STEM CELL THERAPY PRODUCTS OFFERED
    • RTI SURGICAL, INC.
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table RTI SURGICAL, INC.:STEM CELL THERAPY PRODUCTS OFFERED
    • ALLOSOURCE
      • BUSINESS OVERVIEW
      • PRODUCT PORTFOLIO
        • Table ALLOSOURCE:STEM CELL THERAPY PRODUCTS OFFERED
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report